| Q92289426 | A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery |
| Q57154524 | A Review of the Cytokine IL-17 in Ocular Surface and Corneal Disease |
| Q43975900 | A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics. |
| Q70706717 | A new bandage lens for treatment of corneal disease: Softcon XT |
| Q57741848 | A new corneal disease with recurrent erosive episodes and autosomal-dominant inheritance |
| Q52586864 | A novel case using femtosecond laser-acquired lenticule for recurrent pterygium: case report and literature review. |
| Q37737782 | A systematic review on the impact of diabetes mellitus on the ocular surface. |
| Q73569734 | Acremonium keratitis in a patient with herpetic neurotrophic corneal disease |
| Q71425003 | Advances in the diagnosis and management of corneal disease |
| Q34019278 | Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice |
| Q39641763 | An analysis of 1,001 blinding patients with corneal disease in 1960-1989. |
| Q44442147 | An analysis of 1,048 cases of corneal disease |
| Q37338362 | An overview of recent developments in corneal immunobiology: potential relevance in the etiogenesis of corneal disease in the horse |
| Q70655016 | Anterior corneal disease of epidermolysis bullosa simplex |
| Q36412999 | Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease |
| Q35590379 | Applications of contact lens devices in the management of corneal disease |
| Q102061029 | Assessment of response to multimodal management of neurotrophic corneal disease |
| Q72579646 | Atopic corneal disease |
| Q59358017 | Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease |
| Q52590103 | Attitudes and Perception Towards Eye Donation in Patients with Corneal Disease: A Case-controlled Population-based Study. |
| Q33985984 | B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease |
| Q33194711 | Bilateral keratectasia after unilateral laser in situ keratomileusis: A retrospective diagnosis of ectatic corneal disorder |
| Q70216760 | Botulinum toxin A-induced protective ptosis in corneal disease |
| Q45622653 | CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. |
| Q77118784 | CONTRIBUTION TO CORNEAL DISEASE IN SURFACE-FINISHING WORKERS IN A FURNITURE PLANT |
| Q90295446 | Capabilities of Gabor-domain optical coherence microscopy for the assessment of corneal disease |
| Q37322366 | Changing patterns of corneal disease and associated vision loss at a rural African hospital following a training programme for traditional healers |
| Q72361837 | Circulating cornea-specific antibodies in corneal disease and cornea transplantation |
| Q49584457 | Clinical signs in cornea and ocular surface. |
| Q39687051 | Coexistent corneal disease and glaucoma managed by either drainage surgery and subsequent keratoplasty or combined drainage surgery and penetrating keratoplasty |
| Q37732419 | Collagen cross-linking: a new treatment paradigm in corneal disease - a review |
| Q71635313 | Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis |
| Q57498119 | Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland |
| Q90023680 | Comparison of ultrasonic pachymetry and Fourier-domain optical coherence tomography for measurement of corneal thickness in dogs with and without corneal disease |
| Q31043663 | Compensatory epithelial hyperplasia in human corneal disease |
| Q68004706 | Compensatory epithelial hyperplasia in human corneal disease |
| Q41103213 | Component corneal surgery: An update. |
| Q34205430 | Conjunctival flaps for corneal disease: their usefulness and complications |
| Q55037223 | Conjunctival flaps in the treatment of corneal disease with reference to a new technique of application. |
| Q55530374 | Contact Lenses and Corneal Disease: A Programmed Course. |
| Q49584464 | Cornea and anterior eye assessment with slit lamp biomicroscopy, specular microscopy, confocal microscopy, and ultrasound biomicroscopy. |
| Q45990546 | Corneal Nerve Fiber Structure, Its Role in Corneal Function, and Its Changes in Corneal Diseases. |
| Q102050202 | Corneal Stroma Regeneration: New Approach for the Treatment of Cornea Disease |
| Q36932558 | Corneal disease in Africa. |
| Q84712047 | Corneal disease in China |
| Q74596364 | Corneal disease in patients with chronic renal insufficiency undergoing hemodialysis |
| Q43567348 | Corneal disease in rural Transkei. |
| Q69111032 | Corneal disease in the Canadian North |
| Q70307921 | Corneal disease: an approach to primary care |
| Q93827018 | Corneal disorder caused by silver nitrate |
| Q35303136 | Corneoscleral transplantation for end stage corneal disease |
| Q37983964 | Correlation of clinical and pathologic diagnoses of corneal disease in penetrating keratoplasties in Vancouver: a 10-year review |
| Q76998583 | DIAGNOSIS OF CORNEAL DISEASE IN CHILDREN |
| Q39260929 | Descemet stripping automated endothelial keratoplasty |
| Q39266358 | Destructive corneal disease in the connective tissue disorders. Comparison with an experimental animal model |
| Q73342571 | Detection of interleukin-1 beta in the tear fluid of patients with corneal disease with or without conjunctival involvement |
| Q67272450 | Diabetic corneal disease |
| Q72230647 | Diagnosing corneal disease |
| Q36517801 | Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis |
| Q47395148 | Distribution of TFF peptides in corneal disease and pterygium |
| Q64039914 | Drug delivery systems and novel formulations to improve treatment of rare corneal disease |
| Q33624081 | Dystrophia Helsinglandica--corneal morphology, topography and sensitivity in a hereditary corneal disease with recurrent erosive episodes |
| Q41059469 | Early postoperative changes in graft thickness after penetrating keratoplasty. Influence of host corneal disorder on time course |
| Q33982508 | Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits |
| Q43686977 | Effects of vaccination with a Moraxella bovis bacterin on the subsequent development of signs of corneal disease and infection with M bovis in calves under natural environmental conditions |
| Q70065201 | Elevation of tear fluid plasmin in corneal disease |
| Q39411192 | Endothelial keratoplasty versus repeat penetrating keratoplasty after failed penetrating keratoplasty: A systematic review and meta-analysis. |
| Q50763361 | Equine deep stromal abscesses (51 cases - 2004-2009)--Part 1: the clinical aspects with attention to the duration of the corneal disease, treatment history, clinical appearance, and microbiology results. |
| Q41053901 | Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study |
| Q91609090 | Evaluation of equine corneal disease using spectral domain optical coherence tomography (SD-OCT) |
| Q69724074 | Experimental aspects and models of peripheral corneal disease |
| Q36158303 | Feline corneal disease |
| Q67867870 | First experience with highly hydrophilic therapeutic soft contact lenses (With special reference to herpetic corneal disease) (author's transl) |
| Q33972127 | Fluorescein angiography of the anterior segment. Its value in corneal disease |
| Q38811441 | From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU |
| Q38098510 | Future perspectives for regenerative medicine in ophthalmology |
| Q90446296 | Gene-based Therapeutic Tools in the Treatment of Cornea Disease |
| Q40266047 | Genetics of corneal disease for the ocular surface clinician. |
| Q70213325 | Herpes simplex and recurrent corneal disease |
| Q35860009 | High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation |
| Q34072405 | Histopathology and treatment of corneal disease in keratitis, ichthyosis, and deafness (KID) syndrome |
| Q77341407 | Iatrogenic limbal stem cell deficiency: when glaucoma management contributes to corneal disease |
| Q34109376 | Immune mechanisms in Onchocerca volvulus-mediated corneal disease (river blindness). |
| Q91397848 | Impact of corneal disease from patients' and ophthalmologists' perspectives |
| Q90436974 | Indications and prognosis for keratoplasty in eyes with severe visual impairment and blindness due to corneal disease in India |
| Q70896348 | Inflammatory Terrien's Marginal Corneal Disease |
| Q60930937 | Influence of diabetes mellitus on anterior segment of the eye |
| Q36149134 | Inherited corneal disease: the evolving molecular, genetic and imaging revolution |
| Q81276921 | Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis |
| Q33557436 | Intracorneal ring segments in ectatic corneal disease - a review |
| Q44975271 | Intraocular lens implantation after penetrating keratoplasty. Improved unaided visual acuity, astigmatism, and safety in patients with combined corneal disease and cataract |
| Q90392557 | Investigating the Pathogenicity of VSX1 Missense Mutations and Their Association With Corneal Disease |
| Q34497070 | Keratocyte progenitor cell transplantation: A novel therapeutic strategy for corneal disease |
| Q55008627 | Keratoprosthesis: Current global scenario and a broad Indian perspective. |
| Q58777316 | Lamellar keratoplasty techniques |
| Q33194679 | Laser applications for corneal disease |
| Q57817455 | Lectin-Glycan Interactions in Corneal Infection and Inflammation |
| Q36834815 | Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. |
| Q30725386 | Management of coincident corneal disease and cataract |
| Q33581116 | Management of coincidental corneal disease and cataract. |
| Q42914469 | Managing corneal disease: focus on suppurative keratitis. |
| Q47105281 | Matrix regenerative therapy. |
| Q71687278 | Measurement and control of intraocular pressure in corneal disease |
| Q69943519 | Medical therapy of corneal disease |
| Q28071279 | Mesenchymal stem cells for treating ocular surface diseases |
| Q44538630 | Metaherpetic corneal disease in a dog associated with partial limbal stem cell deficiency and neurotrophic keratitis |
| Q93012940 | Modeling Changes in Corneal Parameters With Age: Implications for Corneal Disease Detection |
| Q85728845 | Mosaic chromosome 18q partial deletion syndrome with bilateral full-thickness corneal disease: surgical intervention and histopathology |
| Q43008006 | Mouse genetic corneal disease resulting from transgenic insertional mutagenesis |
| Q39023319 | Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity. |
| Q78539477 | NEW DEVELOPMENTS IN THE TREATMENT OF CORNEAL DISEASE |
| Q42352722 | Neuronal Changes in the Diabetic Cornea: Perspectives for Neuroprotection. |
| Q30423339 | Neurotrophic keratopathy due to dorsolateral medullary infarction (Wallenberg syndrome): case report and literature review |
| Q27694192 | Novel therapeutic approaches for corneal disease |
| Q47163154 | Nrf2, a Potential Therapeutic Target against Oxidative Stress in Corneal Diseases |
| Q55223463 | Observation of corneal transplantation in peripheral corneal disease postoperatively. |
| Q93218730 | Ocular Examination and Corneal Surface Disease in the Ferret |
| Q37337081 | Oculofacial Pain: Corneal Nerve Damage Leading to Pain Beyond the Eye. |
| Q68697049 | Optical pachometry in the measurement of anterior corneal disease: an evaluative tool for phototherapeutic keratectomy |
| Q94936288 | Optimizing outcomes for keratoplasty in ectatic corneal disease |
| Q47547378 | Paraproteinemic keratopathy in monoclonal gammopathy of undetermined significance treated with primary keratoprosthesis: Case report, histopathologic findings, and world literature review |
| Q57600854 | Pars plana tube insertion of glaucoma drainage implants and penetrating keratoplasty in patients with coexisting glaucoma and corneal disease |
| Q54527860 | Partial lamellar keratoplasty for peripheral corneal disease using a graft from the glycerin-preserved corneoscleral rim. |
| Q39917401 | Pattern of bilateral blinding corneal disease in patients waiting for keratoplasty in a tertiary eye care centre in northern India |
| Q84251460 | Pellucid marginal corneal disease in a case of atopic keratoconjunctivitis |
| Q84933496 | Penetrating keratoplasty for unilateral corneal disease: outcomes from a tertiary care hospital in Australia |
| Q26859185 | Phototherapeutic keratectomy |
| Q39966858 | Population-based assessment of vision-related quality of life in corneal disease: results from the CORE study |
| Q90810855 | Population-based assessment of visual impairment and pattern of corneal disease: results from the CORE (Corneal Opacity Rural Epidemiological) study |
| Q36413184 | Pre-Descemet's endothelial keratoplasty |
| Q70982695 | Presence of circulating immune complexes in patients with peripheral corneal disease |
| Q26860955 | Presentation, diagnosis and management of limbal stem cell deficiency |
| Q40121860 | Primary Corneal Disease in the Dog and Cat |
| Q37699104 | Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice |
| Q31027777 | Prospects for gene therapy in corneal disease |
| Q96303873 | Protective effect of high-affinity liposomes encapsulating astaxanthin against corneal disorder in the in vivo rat dry eye disease model |
| Q47160690 | Pseudophakic bullous keratopathy. |
| Q91705991 | Recovering vision in corneal epithelial stem cell deficient eyes |
| Q26853711 | Regenerative medicine for the cornea |
| Q42147903 | Scleral tunnel phacoemulsification: Approach for eyes with severe microcornea |
| Q92091613 | Simple limbal epithelial transplantation (SLET): Review of indications, surgical technique, mechanism, outcomes, limitations, and impact |
| Q88255904 | State of the Art and Beyond: Anterior Segment Diagnostics Genetic Diagnostics in Corneal Disease |
| Q55394892 | Stem cells treatment in the ocular surface regeneration. |
| Q67566323 | Sucralfate and sodium sucrose sulphate in the treatment of superficial corneal disease in keratoconjunctivitis sicca |
| Q36171987 | Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice |
| Q74216790 | Surgical management of corneal disease |
| Q68261726 | Tarsorrhaphy for corneal disease in patients with rheumatoid arthritis |
| Q28346325 | Tear film MMP accumulation and corneal disease |
| Q34644626 | Telemedicine for corneal disease in rural Nepal |
| Q58806014 | The Corneal Basement Membranes and Stromal Fibrosis |
| Q40505327 | The changing character of infectious corneal disease: emerging opportunistic microbial forms (1928-1973). |
| Q71765146 | The hydrophilic (hydron) corneoscleral lens in the treatment of corneal disease |
| Q35006001 | The influence of lamellar orientation on corneal material behavior: biomechanical and structural changes in an avian corneal disorder |
| Q68423095 | The ophthalmic nurse role in the prevention of corneal disease |
| Q39362284 | The prevalence of corneal disease and cataracts in Australian aborigines in Northwestern Australia |
| Q45282631 | The prevalence of corneal disease in the coloured community of a Karoo town. |
| Q74084401 | The use of porcine small intestinal submucosa in ten cases of feline corneal disease |
| Q66960598 | The use of therapeutic soft contact lenses in corneal disease |
| Q34025732 | The use of vital dyes in corneal disease |
| Q67284887 | Therapeutic keratoplasty for active herpetic corneal disease: viral culture and prognosis |
| Q27010179 | Towards the use of hydrogels in the treatment of limbal stem cell deficiency |
| Q58700756 | Tractional Descemet's membrane detachment after ocular alkali burns: case reports and review of literature |
| Q37308866 | Traditional eye medicine use among patients with corneal disease in rural Malawi |
| Q37638761 | Transforming ocular surface stem cell research into successful clinical practice |
| Q70192308 | Treatment and nursing care of corneal disease |
| Q79446637 | Treatment of corneal disease with 5-iodo-2'-deoxyuridine (IDU). A clinical evaluation of 500 cases |
| Q47304601 | Treatment of corneal disease with traditional Tibetan medicine: a report of four cases |
| Q95929764 | Trehalose for Ocular Surface Health |
| Q36377697 | Turning the tide of corneal blindness |
| Q50481505 | Two patients with severe corneal disease in KID syndrome. |
| Q83874819 | Using soybean trypsin inhibitor as an external loading control for Western blot analysis of tear proteins: application to corneal disease |
| Q34684526 | Varicella-zoster virus: mechanisms of pathogenicity and corneal disease |
| Q74517562 | Visual function among corneal disease patients waiting for penetrating keratoplasty in British Columbia |
| Q34981296 | Weill-Marchesani syndrome with advanced glaucoma and corneal endothelial dysfunction: a case report and literature review |
| Q74305291 | What the general physician should know about corneal disease |
| Q95490882 | [A Case of a Corneal Disorder after Breast Cancer Treatment with Nab-paclitaxel] |
| Q84358747 | [A case of a corneal disorder after lung cancer treatment with erlotinib] |
| Q69823224 | [Corneal disease in children] |
| Q75950769 | [Corneal disease in the furniture industry and its significance for industrial hygiene] |
| Q73722138 | [Histopathologic aspects of degenerative and inflammatory disease of cornea] |
| Q72153477 | [Leukocyte migration inhibition test in patients with herpetic corneal disease (author's transl)] |
| Q75654809 | [On the prevention of blindness in corneal disease; medicamental and surgical therapy of ulcus serpens.] |
| Q50464866 | [Patient with severe corneal disease in KID syndrome]. |
| Q84159240 | [Pay attention to a reasonable systemic medication in corneal disease] |
| Q33229861 | [The VF-14 index of functional visual impairment in patients with corneal disease treated by phototherapeutic keratectomy]. |
| Q73434127 | [The current status of the fundamental research in corneal disease in ophthalmology in China] |
| Q71595714 | [Treatment of corneal disease with low voltage contact X-ray (author's transl)] |